[1]Farazi PA, Depinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment[M]. Nat Rev Cancer, 2006,6(9):674-687.
[2]Jazdzewski K, Murray EL, Schoenberg DR,et al. Common SNP in Pre-miR-146a decreases mature miRNA expression and predisposes to papillary thyroid carcinoma[J]. Proc Natl Acad Sci U S A, 2008,105(20):7269-7274.
[3]麦艾. miR-146a异常表达及其单核苷酸多态位点rs2910164与胃癌易感性的相关研究[D]. 广州医科大学,2014.
[4]Hu Z, Liang J, Shen H,et al. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in chinese women[J].Hum Mutat,2009,30(1):79-84.
[5]Cong N, Chen H, Bu WZ,et al.MiR-146a G>C Polymorphisms and risk of hepatocellular carcinoma in a chinese population[J]. Tumour Biol,2014,35(6):5669-5673.
[6]Chen JJ, Cao XD,Zhang HY. miR-146a rs2910164 Polymorphism is associated with hepatocellular carcinoma: a meta-analysis[M].Int J Clin ExP Med,2015,8(9):15852-15856.
[7]Chen M, Luo F, Yu J,et al. Common functional polymorphism within miR-146a and miR-196a-2 as susceptibility loci for hepatocellularcarcinoma: An updated Meta-analysis[M]. Meta Gene,2015, 7:40-47.
[8]Sun N, Sun X, Chen B, et al. MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer[J]. Cancer Chemother Pharmacol,2010,65(3):437-446.
[9]Harbord RM, Egger M, Sterne JA,et al.A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints[J]. Stat Med,2006,25(20):3443-3457.
[10]Qi JH, Wang J, Chen J, et al. High-resolution melting analysis reveals genetic polymorphisms in microRNAs confer hepatocellular carcinoma risk in chinese patients[J].BMC Cancer,2014,14:643.
[11]Zhou B, Dong LP, Zhao LF,et al.Association between miR-146aG>C and miR-196a2C>T polymorphisms and the risk of hepatocellularcarcinoma in a Chinese population[J].Tumour Biol,2014 35(8):7775-7780.
[12]郝玉霞. miR196α基因多态性在原发性肝癌发生发展中的作用及机制研究[D].山西医科大学, 2014.
[13]Kou JT, Fan H, He Q,et al. Association between four common microRNA polymorphisms and the risk of hepatocellular carcinoma and HBV infection[J]. Oncol Lett,2014,8(3):1255-1260.
[14]Shan YF, Huang YH, Zhang QY,et al. miR-499A>G rs3746444 and miR-146aG>C expression and hepatocellular carcinoma risk in the chinese population[J]. Genet Mol Res,2013,12(4):5365-5371.
[15]Li X, Li K, Wu Z.Association of four common SNPs in microRNA polymorphisms with the risk of hepatocellular carcinoma[J]. Int J Clin ExP Pathol,2015,8(8):9560-9566.
[16]Zhang J, Wang R, Liu J,et al. Association between single nucleotide polymorphisms in miRNA196a-2 and miRNA146a and susceptibility to hepatocellular carcinoma in a chinese population[J]. Asian Pac J Cancer Prev,2013,14(11):6427-6431.
[17]Akkiz H, Bayram S, Sandokol M,et al.No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinomadevelopment in Turkish population:a case-control study[J]. Gene,2011,486(1-2):104-109.
[18]张新伟,潘善东,沈洪兵,等.微小RNA前体区域基因多态与肝细胞肝癌遗传易感性关联的研究[J].中华预防医学杂志, 2011, 45(3):239-243.
[19]Zeng Y, Sun QM, Wang B,et al. Correlation between pre-miR-146a C/G polymorphism and gastric cancer risk in chinese population[J]. World J Gastroenterol,2010,16(28):3578-3583.
[20]李玉春.MicroRNA相关单核苷酸多态性与原发性肝癌遗传易感性研究[D]. .郑州大学,2012.
[21]王文章.miR-146a单核苷酸多态与肝癌遗传易感性的关联研究及肿瘤相关microRNA的微阵列分析的研究[D].复旦大学,2011.
[22]黄琼华.miRNA-146a、miRNA-196a2基因多态性与广西壮族人群原发性肝癌的相关性研究[D].广西医科大学,2013.
[23]Li D, Peng JJ, Zhang T,et al.Genetic variations in microRNA genes and susceptibility to hepatocellular carcinoma[J]. Genet Mol Res,2015,14(1):1926-1931.
[24]Xiang Y, Fan S, Zhang LP,et al.Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population[J]. Mol Biol ReP,2012,39(6):7019-7023.
[25]Xu T, Zhu Y, Zhuang SM,et al. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma[J].Carcinogenesis, 2008,29(11):2126-2131.
[26]Zhou J, Lv R, Wang L,et al.Association between two genetic variants in miRNA and primary liver cancer risk in the chinese population[J].DNA Cell Biol,2012,31(4):524-530.
[27]Yan P, Xia M, Gong L,et al.Predictive role of miR-146a rs2910164 (C>G), miR-149 rs2292832 (T>C), miR-196a2 rs11614913 (T>C) and miR-499 rs3746444 (T>C) in the development of hepatocellular carcinoma[J]. Int J Clin ExP Pathol,2015,8(11):15177-15183.
[28]Guan DX, Shi J, Xie D,et al.Sorafenib enriches epithelial cell adhesion molecule-positive tumor initiating cells and exacerbates asubtype of hepatocellular carcinoma through TSC2-AKT cascade[J]. Hepatology,2015,62(6):1791-1803.
[29]Li J, Xu Y, Chen GQ,et al.Cbx4 governs HIF-1α to potentiate angiogenesis of hepatocellular carcinoma by its SUMO E3 ligase activity[J]. Cancer Cell,2014,25(1):118-131.
[30]Liepelt A, Tacke F. Stromal cell-derived factor-1 (SDF-1) as a target in liver diseases[J]. Am J Physiol Gastrointest Liver Physiol,2016,;311(2):G203-209.
[31]Su R, Nan H, Guo H,et al. Associations of components of PTEN/AKT/mTOR pathway with cancer stem cell markers and prognosticvalue of these biomarkers in hepatocellular carcinoma[J]. Hepatol Res,2016,46(13):1380-1391.
[32]Zhang Z, Zhang Y, Sun XX, et al. microRNA-146a inhibits cancer Metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma[J]. Mol Cancer, 2015,14:5.
[33]阮萃才.环境因素与肝癌[J].上海环境科学,1986(5):35-40.
[34]Iakova P, Timchenko L, Timchenko NA. Intracellular signaling and hepatocellular carcinoma[J].Semin Cancer Biol,2011,21(1):28-34.
[35]Teoh NC. Proliferative drive and liver carcinogenesis: too much of a good thing[J]? J Gastroenterol Hepatol, 2009 ,24(12):1817-1825.
[36]Sidhu K, Kapoor NR, Kumar V,et al. The "Macro" world of microRNAs in hepatocellular carcinoma[J].Front Oncol,2015,5:68.
[37]黄宇,黄迪,古维立,等.非乙非丙型肝癌与HBV/HCV相关肝癌的临床特点及预后影响因素分析[J].临床肝胆病杂志,2016.32(3): 514-517.
[38]Stickel N, Prinz G, Pfeifer D,et al.miR-146aregulates the TRAF6/TNF-axis in donor T cells during GVHD[J].Blood,2014,124(16):2586-2595.
[39]Ramkaran P, Khan S, Phulukdaree A, et al.miR-146a polymorphism influences levels of miR-146a, IRAK-1, and TRAF-6 in young patients with coronary artery disease[J].Cell Biochem Biophys,2014,68(2):259-266. |